PARK7 and inflammatory bowel disease: After adjustment for multiple testing, genetically predicted higher levels of PARK7 (OR 0.36, 95% CI 0.25–0.52) and HINT1 (OR 0.47, 95% CI 0.30–0.74) were inversely associated with IBD risk (Fig. 4).